financetom
Business
financetom
/
Business
/
Climate Asset Management has raised more than $1 billion, CEO says
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Climate Asset Management has raised more than $1 billion, CEO says
Sep 29, 2024 7:51 PM

LONDON, Sept 20 (Reuters) - Climate Asset Management has

raised more than $1 billion to invest in natural capital

projects such as regenerative agriculture, its chief executive

told Reuters.

While still a relatively niche area, demand from asset

owners to invest in improving soil health, planting trees and

rehabilitating land has increased in recent years after

countries agreed to do more to protect the world's biodiversity.

The Global Biodiversity Framework, known as the Paris

Agreement for nature, calls for a substantial increase in public

and private finance - by at least $200 billion annually -

towards addressing the nature-related funding gap.

CAM, a tie up between HSBC's ( HSBC ) fund arm and advisory

firm Pollination, said it had seen demand from a range of

financial investors and companies, and that its Natural Capital

Fund and Nature Based Carbon Fund had closed to new money.

The Restore Fund, designed by CAM and tech company Apple ( AAPL )

, remains open and has around $280 million. The balance

of the firm's assets are split roughly across the two closed

funds.

Backers of the Natural Capital Fund included German insurer

Gothaer Asset Management, which contributed $100 million, CAM

said.

The Nature Based Carbon Fund, which aims to generate carbon

credits by investing in large-scale landscape restoration and

conservation projects and will pay investors in these credits,

had seen strong demand from companies like GSK.

Chief Executive Martin Berg, who joined the firm last year,

said nature was moving from a very nascent asset class to

something which was attracting more attention from institutional

investors.

He said nature-related reporting requirements like the

Taskforce for Nature-related Financial Disclosures (TNFD), which

asks companies to report on the impacts they have on the natural

world, were also driving interest in the asset class.

"At first the disclosure obligation was focused on risk, but

soon opened up opportunities to invest, which transferred a

challenge into an opportunity," Berg said.

Berg said the funds have already allocated a significant

portion of the capital raised and that performance was "inline

with expectations."

CAM said it will start fundraising again in 2025.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
China says Qualcomm admitted to acquiring Autotalks without informing regulator
China says Qualcomm admitted to acquiring Autotalks without informing regulator
Oct 12, 2025
HONG KONG (Reuters) -U.S. semiconductor manufacturer Qualcomm ( QCOM ) admitted that it had not informed Chinese authorities when it completed its acquisition of Israel's Autotalks in June, China's market regulator said on Sunday. The disclosure was made two days after China launched an antitrust investigation into Qualcomm ( QCOM ) examining whether the U.S. firm violated China's antitrust law by...
FOCUS-Banquets and billions: How AstraZeneca sealed a US medicine deal with Trump
FOCUS-Banquets and billions: How AstraZeneca sealed a US medicine deal with Trump
Oct 12, 2025
* AstraZeneca ( AZN ) is second drugmaker to clinch Trump deal * CEO Soriot charm offensive began post-2024 US election * Soriot's strategic moves spare company from tariffs * $4.5 billion Virginia plant boosted goodwill with Trump By Maggie Fick LONDON, Oct 12 (Reuters) - AstraZeneca ( AZN ) CEO Pascal Soriot looked relaxed standing in the Oval Office...
Banquets and billions: How AstraZeneca sealed a US medicine deal with Trump
Banquets and billions: How AstraZeneca sealed a US medicine deal with Trump
Oct 12, 2025
LONDON (Reuters) -AstraZeneca CEO Pascal Soriot looked relaxed standing in the Oval Office on Friday as U.S. President Donald Trump unveiled a medicine deal that will lower drug prices for millions of Americans. The hard work had paid off, allowing Soriot to clinch the first agreement for a non-U.S. drugmaker and shield his Anglo-Swedish company from threatened steep tariffs on...
Three workers died at Hyundai's Georgia plant since 2022, before US immigration raid, WSJ reports
Three workers died at Hyundai's Georgia plant since 2022, before US immigration raid, WSJ reports
Oct 12, 2025
Oct 12 (Reuters) - Three workers have died since Hyundai Motor ( HYMLF ) started construction of its $7.6 billion auto plant in Georgia in 2022, the Wall Street Journal reported on Sunday, citing a review of federal records. Dozens of the company's current and former workers, many of them safety coordinators who helped oversee construction, told the newspaper in...
Copyright 2023-2026 - www.financetom.com All Rights Reserved